¼¼°èÀÇ ¸ÂÃãÇü À¯ÀüüÇÐ ½ÃÀå : °Ë»ç À¯Çü, ±â¼ú, ¿ëµµ, ÃÖÁ¾»ç¿ëÀÚ, ±¹°¡ ¹× Áö¿ªº° - »ê¾÷ ºÐ¼®, ½ÃÀå ±Ô¸ð, ½ÃÀå Á¡À¯À², ¿¹Ãø(2023-2030³â)
Personalized Genomics Market, By Test Type, By Technology, By Application, By End User, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2023-2030
»óǰÄÚµå : 1351431
¸®¼­Ä¡»ç : AnalystView Market Insights
¹ßÇàÀÏ : 2023³â 09¿ù
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 277 Pages
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 3,250 £Ü 4,590,000
PDF (Single User License) help
PDF º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠺Ұ¡´ÉÇϸç, ÅØ½ºÆ®ÀÇ Copy&Pasteµµ ºÒ°¡´ÉÇÕ´Ï´Ù.
US $ 4,650 £Ü 6,568,000
PDF (5 User License) help
PDF º¸°í¼­¸¦ µ¿ÀÏ »ç¾÷Àå¿¡¼­ 5¸í±îÁö ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 5,650 £Ü 7,980,000
PDF & Excel (Enterprise User License) help
PDF & Excel º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ ³» ¸ðµç »ç¿ëÀÚ°¡ »ç¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. ÅØ½ºÆ®ÀÇ Copy&Paste °¡´ÉÇÕ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.


¤± Add-on °¡´É: °í°´ÀÇ ¿äû¿¡ µû¶ó ÀÏÁ¤ÇÑ ¹üÀ§ ³»¿¡¼­ CustomizationÀÌ °¡´ÉÇÕ´Ï´Ù. ÀÚ¼¼ÇÑ »çÇ×Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.

Çѱ۸ñÂ÷

¼¼°è ¸ÂÃãÇü À¯ÀüüÇÐ ½ÃÀå ±Ô¸ð´Â 2022³â 90¾ï 870¸¸ ´Þ·¯·Î 2023³âºÎÅÍ 2030³â±îÁö 18.3%ÀÇ CAGR·Î È®´ëµÉ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

¸ÂÃãÇü À¯ÀüüÇÐ ½ÃÀå - ½ÃÀå ¿ªÇÐ

¸ÂÃãÇü À¯ÀüüÇÐ ½ÃÀå - ¼¼ºÐÈ­ ºÐ¼®

¸ÂÃãÇü À¯ÀüüÇÐ ½ÃÀå - Áö¸®Àû ÀλçÀÌÆ®

¿¹Ãø ±â°£ µ¿¾È ºÏ¹Ì Áö¿ªÀÌ ¸ÂÃãÇü À¯ÀüüÇÐ ½ÃÀå¿¡¼­ °¡Àå Å« ½ÃÀå Á¡À¯À²À» Â÷ÁöÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ÀÌ´Â ÀÌ Áö¿ªÀÇ À¯Àüü ±â¼ú äÅà Ȯ´ë, ÁÖ¿ä À¯Àüü ±â¾÷ÀÇ Á¸Àç, Á¤¹ÐÀÇ·á ¿¬±¸¿¡ ´ëÇÑ ÅõÀÚ·Î ÀÎÇÑ °ÍÀ¸·Î ºÐ¼®µË´Ï´Ù. ¶ÇÇÑ, À¯·´ ½ÃÀåÀº À¯Àüü ¿¬±¸¿¡ ´ëÇÑ ÀÚ±Ý Áö¿ø Áõ°¡¿Í ºòµ¥ÀÌÅ͸¦ Ȱ¿ëÇÑ À¯Àüü ÀÇÇÐÀÇ ¹ßÀüÀ¸·Î ÀÎÇØ µÎ ¹øÂ°·Î Å« ½ÃÀåÀ¸·Î ºÎ»óÇÒ °¡´É¼ºÀÌ ³ô½À´Ï´Ù.

¸ÂÃãÇü À¯ÀüüÇÐ ½ÃÀå - °æÀï »óȲ

°Ç°­°ú À¯ÀüÇп¡ ´ëÇÑ ¼ÒºñÀÚÀÇ °ü½É Áõ°¡, °³ÀÎ ¸ÂÃãÇü ÀÇ·á, ±â¼ú ¹ßÀüÀ¸·Î ¸ÂÃãÇü À¯ÀüüÇÐ ½ÃÀåÀº Å©°Ô ¼ºÀåÇϰí ÀÖ½À´Ï´Ù. ´õ ¸¹Àº ¿ëµµ¿Í ÀλçÀÌÆ®ÀÌ µîÀåÇÔ¿¡ µû¶ó ½ÃÀåÀº °è¼Ó È®´ëµÉ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ¶ÇÇÑ, À¯ÀüÀÚ ¿°±â¼­¿­ ºÐ¼® ±â¼ú, ¿¬±¸, µ¥ÀÌÅÍ ºÐ¼®ÀÇ ¹ßÀüÀ¸·Î ¸ÂÃãÇü À¯ÀüüÇÐ ½ÃÀåÀº ºü¸£°Ô ÁøÈ­Çϰí ÀÖ½À´Ï´Ù. ÇöÀç ÁøÇà ÁßÀÎ °øµ¿ ¿¬±¸¿Í ¿¬±¸´Â ÀÇ·á ºÐ¾ßÀÇ À¯ÀüÇÐ ¹× ±× Ư¼º¿¡ ´ëÇÑ ½ÉÃþÀûÀÎ ÀÌÇØ¿¡ ±â¿©Çϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ, ÀÓ»ó Àû¿ëÀ» È®´ëÇϱâ À§ÇØ ¹Î°£ ¹× °ø°ø ºÎ¹® ¸ðµÎ À¯Àüü ¿¬±¸¿¡ ¸¹Àº ÅõÀÚ¸¦ Çϰí ÀÖ½À´Ï´Ù. À¯Àü¼º Áúȯ °Ë»ç Áý´Ü À¯ÀüüÇÐ, Á¤¹Ð Á¾¾çÇÐ, ¾à¸®À¯ÀüüÇÐ µîÀÇ ºÐ¾ß¿¡¼­ ³ôÀº ¼öÁØÀÇ ¿¬±¸ °³¹ßÀÌ ÀÌ·ç¾îÁö°í ÀÖ½À´Ï´Ù. ¿¹¸¦ µé¾î, Ç︯½º(Helix)¿Í Ç︯½º(Helix)´Â ³×ºê·¡½ºÄ« ÁÖ Àü ±¹¹ÎÀ» ´ë»óÀ¸·Î Á¤¹Ð ÀǷḦ ÃËÁøÇÏ´Â Áý´Ü À¯ÀüüÇÐ ÇÁ·Î±×·¥ÀÎ 'À¯ÀüÀû ÀλçÀÌÆ® ÇÁ·ÎÁ§Æ®(Genetic Insights Project)'¸¦ ½ÃÀÛÇÑ´Ù°í ¹ßÇ¥Çß½À´Ï´Ù. ÀÌ ¿¬±¸ ÇÁ·Î±×·¥Àº ÇÑ ¹øÀÇ °Ë»ç·Î Âü°¡ÀÚÀÇ ´Ù¾çÇÑ ¾Ï°ú »ý¸íÀ» À§ÇùÇÒ ¼ö ÀÖ´Â Áúº´¿¡ ´ëÇÑ À§ÇèÀ» ÆÄ¾ÇÇÏ¿© °³º° ȯÀÚÀÇ »îÀ» °³¼±ÇÏ´Â µ¥ µµ¿òÀ» ÁÙ »Ó¸¸ ¾Æ´Ï¶ó Áö¿ª ÀüüÀÇ ¸ðµç »ç¶÷ÀÇ Ãß¼¼¸¦ ÆÄ¾ÇÇÏ´Â °ÍÀ» ¸ñÇ¥·Î Çϰí ÀÖ½À´Ï´Ù.

¸ñÂ÷

Á¦1Àå ¸ÂÃãÇü À¯ÀüüÇÐ ½ÃÀå °³¿ä

Á¦2Àå ÁÖ¿ä ¿ä¾à

Á¦3Àå ¸ÂÃãÇü À¯ÀüüÇÐ ÁÖ¿ä ½ÃÀå µ¿Çâ

Á¦4Àå ¸ÂÃãÇü À¯ÀüüÇÐ »ê¾÷ Á¶»ç

Á¦5Àå ¸ÂÃãÇü À¯ÀüüÇÐ ½ÃÀå : COVID-19ÀÇ ¿µÇ⠺м®

Á¦6Àå ¸ÂÃãÇü À¯ÀüüÇÐ ½ÃÀå »óȲ

Á¦7Àå ¸ÂÃãÇü À¯ÀüüÇÐ ½ÃÀå - °Ë»ç À¯Çüº°

Á¦8Àå ¸ÂÃãÇü À¯ÀüüÇÐ ½ÃÀå - ±â¼úº°

Á¦9Àå ¸ÂÃãÇü À¯ÀüüÇÐ ½ÃÀå - ¿ëµµº°

Á¦10Àå ¸ÂÃãÇü À¯ÀüüÇÐ ½ÃÀå - ÃÖÁ¾»ç¿ëÀÚº°

Á¦11Àå ¸ÂÃãÇü À¯ÀüüÇÐ ½ÃÀå - Áö¿ªº°

Á¦12Àå ÁÖ¿ä º¥´õ ºÐ¼® - ¸ÂÃãÇü À¯ÀüüÇÐ »ê¾÷

Á¦13Àå ¾Ö³Î¸®½ºÆ®ÀÇ Àü¹æÀ§ Àü¸Á

ksm
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

REPORT HIGHLIGHT

Personalized genomics market size was valued at USD 9,008.7 Million in 2022, expanding at a CAGR of 18.3% from 2023 to 2030.

The personalized genomics market is defined as the growing field of genomics and genetics that focuses on tailoring medical treatments, lifestyle recommendations, and interventions based on an individual's genetic makeup. Additionally, it involves the analysis of an individual's genetic information to offer personalized insights into their disease risk, health, and potential response to numerous therapies. The key drivers such as the focus on preventive medicine, declining costs of genomic sequencing, and rising demand for personalized therapies are increasing the market demand.

Personalized Genomics Market - Market Dynamics:

Personalized Genomics Market - Key Insights:

Personalized Genomics Market- Segmentation Analysis:

Personalized Genomics Market- Geographical Insights

North America is projected to hold the largest market share for Personalized Genomics over the forecast period. This is attributed to the growing adoption of genomic technologies, the presence of leading genomics companies, and investments in precision medicine research in the region. Furthermore, the European market is likely to be the second-largest market owing to the increasing funding for genomic research and advancements in genomic medicine using big data.

Personalized Genomics Market- Competitive Landscape:

Increasing consumer interest in health and genetics, personalized healthcare, and advancements in technology are witnessing significant growth in the personalized genomics market. As more applications and insights emerge, it is expected to continue expanding. Moreover, the personalized genomics market continues to evolve quickly due to the advances in genetic sequencing technology, research, and data analysis. Ongoing collaborations and studies contribute to a detailed understanding of genetics and its properties in healthcare. Furthermore, to expand clinical applications significant investments are being channeled into genomic research from both private and public sectors. There is high R&D in areas such as hereditary disease testing population genomics, precision oncology, and pharmacogenomics. For instance, Helix and Helix announced a partnership to launch a population genomics program to drive precision medicine for all individuals in Nebraska known as the Genetic Insights Project. The research program will identify participants' risk for various cancers and other potentially life-threatening diseases with a single test, with the aim of not only assisting to improve the lives of individual patients but also identifying trends for everyone across the region.

Recent Developments:

For instance, in January 2022, Exact Sciences Corp. acquired Prevention Genetics, a genetic testing laboratory, to complement its advanced cancer diagnostics portfolio and support its entrance into hereditary cancer testing (HCT). Additionally, prevention genetics offers the expertise, clinical lab, and foundational technology necessary to accelerate the availability of HCT and assist more patients in knowing their germline risk of cancer and other diseases.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL PERSONALIZED GENOMICS MARKET KEY PLAYERS

GLOBAL PERSONALIZED GENOMICS MARKET, BY TEST TYPE

GLOBAL PERSONALIZED GENOMICS MARKET, BY TECHNOLOGY

GLOBAL PERSONALIZED GENOMICS MARKET, BY APPLICATION

GLOBAL PERSONALIZED GENOMICS MARKET, BY END USER

GLOBAL PERSONALIZED GENOMICS MARKET, BY REGION

Table of Contents

1. Personalized Genomics Market Overview

2. Executive Summary

3. Personalized Genomics Key Market Trends

4. Personalized Genomics Industry Study

5. Personalized Genomics Market: COVID-19 Impact Analysis

6. Personalized Genomics Market Landscape

7. Personalized Genomics Market - By Test Type

8. Personalized Genomics Market - By Technology

9. Personalized Genomics Market - By Application

10. Personalized Genomics Market - By End User

11. Personalized Genomics Market- By Geography

12. Key Vendor Analysis- Personalized Genomics Industry

13. 360 Degree Analyst View

14. Appendix

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â